A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma

Table 3 Less Time Required for in vivo Expansion of P2 and P3 Subcutaneous PDX Tissues

Passage	Patient 1275	Patient 1319
Days Required for in vivo Expansion of Subcutaneous PDX Tissues
P1	57	50
P2	34	34
P3	42	22

PDX: patient-derived xenograft; P1: first passage; P2: second passage; P3: third passage

ISSN: 1479-5876